文献速递肺外科心外重症与机械循环支持

循环死亡后供肺与离体肺灌注肺移植的结局

Outcomes of donation after circulatory death (DCD) and ex-vivo lung perfusion (EVLP) lung transplantation.
PubMed 文献 · J Heart Lung Transplant · 2024-10-09

该研究基于UNOS数据库2015年1月至2023年3月的成人肺移植数据,比较了循环死亡后捐献(DCD)与脑死亡后捐献(DBD)肺移植的结局,并分析了离体肺灌注(EVLP)的影响。结果显示DCD肺移植总体生存与DBD无显著差异,但再插管和ECMO使用增加;DCD联合EVLP者现代期生存显著较差,EVLP是DCD队列移植物失败的独立危险因素。

要点

  • DCD肺移植总体生存与DBD相当,但再插管和ECMO使用增加。
  • DCD联合EVLP者现代期生存显著较差,EVLP为DCD移植物失败独立危险因素。
  • DCD+EVLP队列中肺动脉高压、移植前输血、肌酐升高和高分配评分与移植物失败和死亡相关。

核心结论

  • DCD肺移植未行EVLP者生存与DBD相当,但围术期并发症有所增加。
  • DCD肺移植行EVLP者死亡和围术期并发症风险增加,需谨慎选择受者。

研究设计与样本

  • 回顾性队列研究,查询UNOS数据库2015年1月1日至2023年3月1日成人肺移植。
  • 排除失访、多器官移植和既往肺移植。
  • 比较DCD与DBD肺移植,并按是否使用EVLP进行亚组分析。
  • 纳入DCD 1,103例(EVLP 221例,无EVLP 882例)和DBD 17,973例(EVLP 524例,无EVLP 17,449例)。
  • 中位随访3年,结局为生存和术后并发症。

主要发现

  • DCD供者CDC高风险比例(19.3% vs 24.1%,p<0.001)、支气管镜脓性分泌物(13.3% vs 18.3%,p<0.001)和胸片浸润影(66.7% vs 67.8%,p=0.013)均低于DBD供者。
  • EVLP在DCD移植中更常用(20.0% vs 2.9%,p<0.001)。
  • DCD受者再插管(24.3% vs 18.5%,p<0.001)和72小时内ECMO(14.9% vs 7.8%,p<0.001)比例更高。
  • 调整后生存分析显示DCD与DBD移植总体生存无显著差异(早期p=0.774,现代期p=0.468)。
  • 现代期DCD+EVLP队列生存显著较差(p=0.005),EVLP是DCD队列移植物失败的独立危险因素(HR 1.33,95%CI 1.00-1.77,p=0.047),对DBD无显著影响(p=0.870)。

临床怎么用

  • DCD肺移植未行EVLP者可考虑作为扩大供体池的选择,但需警惕再插管和ECMO风险。
  • DCD肺移植联合EVLP需谨慎选择受者,尤其避免用于肺动脉高压、移植前输血、肌酐升高或高分配评分者。

局限性

  • 回顾性数据库研究,存在选择偏倚和未测量混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Donation after circulatory death (DCD) and ex-vivo lung perfusion (EVLP) have been adopted to expand the donor pool in lung transplantation, but outcomes data have been conflicting. This study explores outcomes of DCD and EVLP lung transplantation in the modern era. METHODS: The United Network for Organ Sharing database was queried for adult lung transplants from January 1, 2015 to March 1, 2023. Loss to follow-up, multiorgan, and prior lung transplants were excluded. DCD versus donation after brain death (DBD) lung transplants were compared with subgroup analysis +/- EVLP. Outcomes were survival and postoperative complications. RESULTS: The study included 1,103 DCD (221 with EVLP and 882 without) and 17,973 DBD lung transplants (524 with EVLP and 17,449 without). Median follow-up was 3 years. DCD donors were less likely to be CDC high risk (19.3% vs 24.1%, p < 0.001), have purulence on bronchoscopy (13.3% vs 18.3%, p < 0.001), or infiltrates on chest X-ray (66.7% vs 67.8%, p = 0.013). EVLP was more likely to be used for DCD transplants (20.0% vs 2.9%, p < 0.001). After transplant, DCD recipients were more likely to be reintubated (24.3% vs 18.5%, p < 0.001) and require ECMO within 72 hours (14.9% vs 7.8%, p < 0.001), and DCD donation was an independent risk factor for these complications on multivariable logistic regression. Overall survival did not differ significantly between DCD and DBD transplants on adjusted survival analysis in the early or modern era (p = 0.774 and p = 0.468, respectively). On subgroup analysis, the DCD+EVLP cohort had significantly worse survival in the modern era, which remained significant after adjusting for donor and recipient factors (p = 0.005). EVLP was an independent risk factor for graft failure in the DCD cohort (hazard ratio [HR] 1.33, 95% confidence interval [CI] 1.00-1.77, p = 0.047) but did not significantly affect DBD graft survival (p = 0.870). Risk factors for graft failure and mortality in the DCD+EVLP cohort included pulmonary hypertension (HR 77.5, 95% CI 6.15-979, p < 0.001), transfusion before transplant (HR 2.60, 95% CI 1.07-6.31, p = 0.035), elevated creatinine (HR 2.82, 95% CI 1.34-5.90, p = 0.006), and higher allocation score (HR 1.02, 95% CI 1.00-1.04, p = 0.017) CONCLUSIONS: Study findings suggest increased risks of mortality and perioperative complications following transplantation with DCD lungs that have undergone EVLP. DCD lung transplantation without EVLP confers equivalent survival but with some increase in perioperative complications. Further investigation and careful recipient selection are warranted to optimize the use of these extended criteria donors in the modern era.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Li SS, Funamoto M, Singh R, et al. Outcomes of donation after circulatory death (DCD) and ex-vivo lung perfusion (EVLP) lung transplantation. J Heart Lung Transplant. 2024. PMID: 39389331. doi:10.1016/j.healun.2024.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。